SEC Form 4 · accession 0000950138-18-000568
Elanco Animal Health Inc · ELAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sarena S Lin
Officer — See Remarks
Period of report
Oct 20, 2018
Accepted (ET)
Oct 23, 2018 · 6:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001739104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 20, 2018 | A | 6,979 | $0.00 | A | 26,979 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right-to-Buy)F2 | $31.61 | Oct 20, 2018 | A | 21,086 | A | — | Oct 20, 2028 | Elanco Animal Health Inc. Common Stock | 21,086 | 21,086 | D |
Explanation of responses
- F1Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021.
- F2Grant of stock option pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021.
Remarks
Executive Vice President, Elanco USA and Global Strategy. Exhibit 24 - Power of Attorney for Sarena Lin